Results 2,101-2,120 of 3,871 for speaker:Catherine Byrne

Written Answers — Department of Health: Drug Treatment Programmes (16 Sep 2016)

Catherine Byrne: I propose to take Questions Nos. 1185 and 1186 together. As these are service matters, they have been referred to the Health Service Executive for attention and direct reply to the Deputy.

Written Answers — Department of Health: Health Services (16 Sep 2016)

Catherine Byrne: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.

Written Answers — Department of Health: National Drugs Strategy (16 Sep 2016)

Catherine Byrne: As the Deputy will be aware, a Steering Committee, with an independent chair, has been established to advise me on a new National Drugs Strategy, which will commence in 2017, when the current policy expires. On 6 September, I announced the details of a public consultation in order to assist the Steering Committee determine the key priorities to be addressed in the new Strategy. The public...

Pharmacy Fees: Motion [Private Members] (27 Sep 2016)

Catherine Byrne: I am speaking on behalf of the Minister, who had to leave. I thank all of those who contributed to the debate and I have taken note of a lot of the issues that were raised, in particular community pharmacists. Many of them have dedicated their lives to working in communities, have gotten to know people and their families and relate to them on a one-to-one basis. We are all fully aware...

Written Answers — Department of Health: Misuse of Drugs (27 Sep 2016)

Catherine Byrne: The Misuse of Drugs (Amendment) Act 2016 was passed by the Oireachtas on the 21stJuly 2016. The primary purpose of the Act is to protect public health by bringing certain substances which are open to misuse and known to be traded on the illicit market under the scope of the Misuse of Drugs legislation, thereby aiding the law enforcement activities of An Garda Síochána. These include...

Written Answers — Department of Health: Direct Provision System (27 Sep 2016)

Catherine Byrne: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.

Written Answers — Department of Health: Medicinal Products Licensing (27 Sep 2016)

Catherine Byrne: Under European and Irish legislation, before a medicine can be placed on the Irish market the manufacturer has to seek an authorisation from the Health Products Regulatory Authority (HPRA) or in the case of certain medicinal products, the European Medicines Agency (EMA). A determination on an application for authorisation of a medicine is based on a rigorous scientific assessment of the...

Written Answers — Department of Health: National Drugs Strategy Implementation (27 Sep 2016)

Catherine Byrne: I meet regularly with Minister Harris and the other Ministers of State in the Department of Health to discuss matters of mutual interest. Such arrangements may be either formal or informal, as the circumstances require. I intend to liaise with all appropriate cabinet Ministers to ensure that the new National Drugs Strategy, which will commence in 2017, provides an up-to-date and effective...

Written Answers — Department of Health: National Drugs Strategy (27 Sep 2016)

Catherine Byrne: I propose to take Questions Nos. 590 and 593 together. I have overall responsibility for the implementation of the National Drugs Strategy 2009-2016, which addresses the issue of problem drug use through five inter-connected pillars dealing with supply reduction, prevention (including education & awareness), treatment, rehabilitation and research. The Oversight Forum on Drugs (OFD)...

Written Answers — Department of Health: National Drugs Strategy (27 Sep 2016)

Catherine Byrne: As the Deputy will be aware, a Steering Committee, with an independent chair, has been established to advise me on a new National Drugs Strategy, which will commence in 2017, when the current policy expires. On 6 September, I announced the details of a public consultation in order to assist the Steering Committee determine the key priorities to be addressed in the new Strategy. The public...

Written Answers — Department of Health: National Drugs Strategy Implementation (27 Sep 2016)

Catherine Byrne: Government policy in relation to drugs underlines the importance of providing opportunities for people to move on from illicit drug use to a drug-free life, where that is achievable. In line with the National Drugs Strategy, the Health Service Executive has reoriented the addiction services in recent years so that they are capable of dealing with all substances. The HSE is continuing to...

Written Answers — Department of Health: Health Products Regulatory Authority (27 Sep 2016)

Catherine Byrne: The Health Products Regulatory Authority (HPRA) works in conjunction with Revenue’s Customs Service regarding importations to Ireland, and with An Garda Síochána regarding supplies within Ireland, in order to detect illicit supplies of anabolic steroid containing medicines for abuse purposes. Anabolic steroids are synthetic versions of the male hormone testosterone. They...

Written Answers — Department of Health: Drug Treatment Programmes (28 Sep 2016)

Catherine Byrne: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.

Written Answers — Department of Health: Drug Treatment Programmes (29 Sep 2016)

Catherine Byrne: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.

Written Answers — Department of Health: Drug Treatment Programmes Funding (4 Oct 2016)

Catherine Byrne: I propose to take Questions Nos. 350, 351, 353, 406, 411, 412, 417, 428, 469 and 475 to 477, inclusive, together. As the Deputy will be aware, a Steering Committee, with an independent chair, has been established to advise me on a new National Drugs Strategy, which will take effect in 2017, when the current policy expires. The provision of resources to support the implementation of the new...

Written Answers — Department of Health: Departmental Funding (4 Oct 2016)

Catherine Byrne: I propose to take Questions Nos. 419 and 420 together. The Department of Health does not directly engage with other Departments regarding the specific funding of individual service providers, contracted by or on behalf of the Health Service Executive, including the Aislinn Service of Aiséiri. The Oversight Forum on Drugs (OFD), which I chair, is responsible for the high-level...

Written Answers — Department of Health: National Drugs Strategy Budget (4 Oct 2016)

Catherine Byrne: As the Deputy will be aware, a Steering Committee, with an independent chair, has been established to advise me on a new National Drugs Strategy, which will take effect in 2017, when the current policy expires The provision of resources to support the implementation of the new Strategy will be determined in the context of the estimates process.

Written Answers — Department of Health: Drug and Alcohol Task Forces (5 Oct 2016)

Catherine Byrne: It is assumed that the Deputy is referring to staff employed to support the day-to-day operation of Local and Regional Drug and Alcohol Task Forces and HSE Addiction Service staff. Drug and Alcohol Task Force coordinators are, in the main, employed by the Health Service Executive (HSE). However, the HSE also allocates funding to Drug and Alcohol Task Forces for other support workers,...

Written Answers — Department of Health: Voluntary Sector Funding (6 Oct 2016)

Catherine Byrne: As the Deputy will be aware, a Steering Committee, with an independent chair, has been established to advise me on a new National Drugs Strategy, which will take effect in 2017, when the current policy expires. The provision of resources to support the implementation of the new Strategy, including detoxification services for young people and adolescents, will be determined in the context of...

Written Answers — Department of Health: Youth Services Data (11 Oct 2016)

Catherine Byrne: Drug and Alcohol Task Forces are responsible for developing measures to address drug problems in their areas having regard to local needs. As part of their work, many Task Forces have developed measures to support projects targeting young people at risk of using drugs. Funding for such measures is either provided to the Task Force projects directly by the Health Service Executive or...